Intel Analysts Chase the Stock Higher, But Earnings Loom Large

Short interest tells a de-risking story rather than a directional one. SI as a percentage of the free float has dropped 15% over the past week to 2.6%, continuing a steady unwind that began in early July. Borrow conditions reinforce the same message — availability is effectively unlimited, with over 4.4 billion shares available to lend against roughly 124 million sold short. Cost to borrow ticked up 12% on the week to 0.47% but remains low in absolute terms. There is no squeeze dynamic here, no lending-market stress, and no sign that short sellers are fighting the tape. The ORTEX short score has also drifted lower, falling from around 31 to 29.8 over the past ten days. Shorts have been covering into the stock's weakness, not adding into a bear thesis.

Options positioning adds little incremental information. The put/call ratio is 0.98, almost exactly in line with its 20-day average of 0.98, with a z-score near zero. At a 52-week low of 0.61 and a high of 1.16, the current reading sits in the middle of the range — options traders are neither loading up on protection nor betting aggressively on continued upside. That neutrality is somewhat surprising given how much the stock has moved: down 13% over the past month from the June peak, yet up 4.5% on Tuesday alone. The muted PCR suggests the options market is waiting for the earnings print rather than pre-positioning around it.

The institutional ownership picture adds useful context. BlackRock added over 15 million shares through June 30, its most recent filing, bringing its stake to 8.9% of shares. Capital Research added 26.7 million shares. FMR (Fidelity) added 26.7 million. These are meaningful additions from long-only managers — not speculative positioning — and they suggest that despite the price volatility, large institutional holders were building into the weakness during Q2, not fleeing it. The insider picture is quieter: the CFO sold roughly $2 million of stock in early June at prices around $110, close to where the stock trades now, while net insider activity over 90 days is modestly positive in share terms.

The July 23 earnings report now defines everything — not just for Intel but for the Street's repricings of the past two weeks. Analysts have raised targets in advance of the print, which either validates their conviction or front-runs a disappointment. The lone prior earnings data point of note is the April 23 release, which produced a 26% one-day gain and a 45% five-day gain — a genuinely extraordinary reaction to whatever was in that print. With the stock now trading around $108, the setup heading into the next release is what to watch: whether the surge of analyst upgrades continues, whether short sellers reverse course and rebuild positions, or whether the Street's cautious-but-repricing posture holds through the report.

Intel closes June at $139.63, up 6% on the day and 22% for the month, and for the first time in this note's recent run the stock is no longer alone in re-rating higher — the Street has started to follow. The most…